Discontinued — last reported Q1 '18
Allowance for Doubtful Accounts Receivable (Current)
STERIS Allowance for Doubtful Accounts Receivable (Current) increased by 7.4% to $29.10M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 30.1%, from $22.36M to $29.10M. Over 4 years (FY 2021 to FY 2025), Allowance for Doubtful Accounts Receivable (Current) shows an upward trend with a 21.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
Detailed definition
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Peer comparison
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_currentHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $17.66M | $18.41M | $21.12M | $24.37M | $23.12M | $22.20M | $25.14M | $23.43M | $24.37M | $27.12M | $27.95M | $22.98M | $23.68M | $24.48M | $22.36M | $24.40M | $25.60M | $27.10M | $29.10M |
| QoQ Change | — | +4.3% | +14.7% | +15.4% | -5.1% | -4.0% | +13.3% | -6.8% | +4.0% | +11.3% | +3.1% | -17.8% | +3.0% | +3.4% | -8.7% | +9.1% | +4.9% | +5.9% | +7.4% |
| YoY Change | — | — | — | — | +30.9% | +20.6% | +19.0% | -3.9% | +5.4% | +22.2% | +11.2% | -1.9% | -2.8% | -9.7% | -20.0% | +6.2% | +8.1% | +10.7% | +30.1% |
Allowance for Doubtful Accounts Receivable (Current) at Other Companies
Frequently Asked Questions
- What is STERIS's allowance for doubtful accounts receivable (current)?
- STERIS (STE) reported allowance for doubtful accounts receivable (current) of $29.10M in Q4 2025.
- How has STERIS's allowance for doubtful accounts receivable (current) changed year-over-year?
- STERIS's allowance for doubtful accounts receivable (current) increased by 30.1% year-over-year, from $22.36M to $29.10M.
- What is the long-term trend for STERIS's allowance for doubtful accounts receivable (current)?
- Over 4 years (2021 to 2025), STERIS's allowance for doubtful accounts receivable (current) has grown at a 21.1% compound annual growth rate (CAGR), from $11.36M to $24.40M.
- What does allowance for doubtful accounts receivable (current) mean?
- The estimated portion of customer invoices that the company expects will never be paid.